Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis-Reference-Cited by-同舟云学术

Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis

Published:2006-06-28 Issue:4 Volume:155 Page:722-728
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Caproni M.,Torchia D.,Schincaglia E.,Volpi W.,Frezzolini A.,Schena D.,Marzano A.,Quaglino P.,De Simone C.,Parodi A.,Barletta E.,Fabbri P.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2006.07398.x/fullpdf

Reference30 articles.

1. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme;Bastuji-Garin;Arch Dermatol,1993

2. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes;Assier;Arch Dermatol,1995

3. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome and toxic epidermal necrolysis: results of an international prospective study;Auquier-Dunant;Arch Dermatol,2002

4. HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme;Khalil;J Invest Dermatol,1991

5. Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response;Kokuba;Br J Dermatol,1998

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study;Frontiers in Immunology;2024-08-07

2. Recurrent erythema multiforme in the setting of COVID-19 infection and oral candidiasis: A case for dysregulation of the T helper 17/interleukin 17 axis;JAAD Case Reports;2024-07

3. A systematic review of case–control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis;Australasian Journal of Dermatology;2024-06-03

4. Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review;Current Opinion in Allergy & Clinical Immunology;2024-05-17

5. Unique cytokine signature in ocular Stevens-Johnson syndrome non-responders;The Ocular Surface;2024-04